Prosight Management’s Bristol-Myers Squibb BMY Stock Holding History

Prosight Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-95,600	Closed	-$6.04M	–	49
2021 Q1	$6.04M	Sell	95,600 -73,400	-43%	-$4.57M	4.94%	6
2020 Q4	$10.5M	Sell	169,000 -16,500	-9%	-$1.01M	4.84%	6
2020 Q3	$11.2M	Buy	185,500 +67,500	+57%	+$4.06M	5.32%	3
2020 Q2	$6.94M	Buy	+118,000	New	+$7.06M	2.98%	12
2020 Q1	–	Sell	-8,100	Closed	-$520K	–	47
2019 Q4	$520K	Sell	8,100 -296,800	-97%	-$17M	0.23%	37
2019 Q3	$15.5M	Sell	304,900 -105,590	-26%	-$4.96M	8.58%	2
2019 Q2	$18.6M	Buy	410,490 +127,490	+45%	+$5.94M	9.39%	2
2019 Q1	$13.5M	Buy	+283,000	New	+$14.1M	5.91%	5

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Prosight Management's BMY Position: Q2 2021 in Review

Prosight Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 95,600 shares — an estimated $6.04M sold.

Prosight Management first reported a position in BMY in Q1 2019 and held it in 8 quarters. The position peaked at $18.6M in Q2 2019. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Prosight Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Prosight Management sold 95,600 Bristol-Myers Squibb shares in Q2 2021, an estimated $6.04M.
Prosight Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 8 quarters.
Prosight Management's Bristol-Myers Squibb position peaked at $18.6M in Q2 2019.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Prosight Management's 13F filing for Q2 2021, filed 13 Aug 2021.